Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Choi

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|February 5, 2020
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports ProgramJavier Jimenez, Eran C Gwillim, Cory Kosche, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|May 23, 2009
Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomesC Max Schmidt, Jennifer Choi, Emilie S Powell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
The Journal of Surgical Research|March 27, 2009
Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinomaMatthew Hennig, Michele T Yip-Schneider, Patrick Klein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Clinical Breast Cancer|May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxaneShanu Modi, Violante E Currie, Andrew D Seidman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Journal of Surgical Education|March 19, 2023
Outcomes of the 2021-2022 APDS General Surgery Recruitment Process RecommendationsJennifer LaFemina, Kari M Rosenkranz, Cary B Aarons, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|February 5, 2020
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports ProgramJavier Jimenez, Eran C Gwillim, Cory Kosche, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|May 23, 2009
Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomesC Max Schmidt, Jennifer Choi, Emilie S Powell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
The Journal of Surgical Research|March 27, 2009
Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinomaMatthew Hennig, Michele T Yip-Schneider, Patrick Klein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Clinical Breast Cancer|May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxaneShanu Modi, Violante E Currie, Andrew D Seidman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Journal of Surgical Education|March 19, 2023
Outcomes of the 2021-2022 APDS General Surgery Recruitment Process RecommendationsJennifer LaFemina, Kari M Rosenkranz, Cary B Aarons, et al.
Pageof 8